Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1955 2
1956 1
1959 1
1963 2
1964 7
1965 6
1966 1
1967 5
1968 5
1969 6
1970 4
1971 7
1972 9
1973 9
1974 14
1975 17
1976 13
1977 12
1978 12
1979 14
1980 16
1981 21
1982 19
1983 33
1984 43
1985 54
1986 37
1987 34
1988 44
1989 50
1990 56
1991 60
1992 52
1993 63
1994 73
1995 77
1996 64
1997 80
1998 74
1999 84
2000 96
2001 93
2002 106
2003 103
2004 116
2005 158
2006 181
2007 122
2008 145
2009 147
2010 143
2011 157
2012 172
2013 142
2014 185
2015 218
2016 247
2017 256
2018 255
2019 261
2020 278
2021 310
2022 311
2023 283
2024 116

Text availability

Article attribute

Article type

Publication date

Search Results

5,277 results

Results by year

Filters applied: . Clear all
Page 1
Prebiotics-Encapsulated Probiotic Spores Regulate Gut Microbiota and Suppress Colon Cancer.
Zheng DW, Li RQ, An JX, Xie TQ, Han ZY, Xu R, Fang Y, Zhang XZ. Zheng DW, et al. Adv Mater. 2020 Nov;32(45):e2004529. doi: 10.1002/adma.202004529. Epub 2020 Oct 1. Adv Mater. 2020. PMID: 33006175
While microbial-based therapy has been considered as an effective strategy for treating diseases such as colon cancer, its safety remains the biggest challenge. Here, probiotics and prebiotics, which possess ideal biocompatibility and are extensively used as additiv …
While microbial-based therapy has been considered as an effective strategy for treating diseases such as colon cancer, its saf …
Design of novel chemotherapeutic delivery systems for colon cancer therapy based on oral polymeric nanoparticles.
Mishra B, Chaurasia S. Mishra B, et al. Ther Deliv. 2017 Jan;8(1):29-47. doi: 10.4155/tde-2016-0058. Epub 2016 Dec 16. Ther Deliv. 2017. PMID: 27982736 Review.
Oral delivery of cancer chemotherapeutic drugs (CCDs) is subject matter in the 21st century, which changes the dosage regimens of oncotherapy with enhancement in patient's life and deducts the cost of therapy. The present report explored on the nano-oncology such as …
Oral delivery of cancer chemotherapeutic drugs (CCDs) is subject matter in the 21st century, which changes the dosage regimens …
Antibodies to oral pathobionts and colon cancer risk in the CLUE I cohort study.
Debertin J, Teles F, Martin LM, Lu J, Koestler DC, Kelsey KT, Beck JD, Platz EA, Michaud DS. Debertin J, et al. Int J Cancer. 2023 Jul 15;153(2):302-311. doi: 10.1002/ijc.34527. Epub 2023 Apr 9. Int J Cancer. 2023. PMID: 36971101
The objective of our study was to investigate the association of antibodies to oral bacteria and the risk of colon cancer in a cohort setting. Using the CLUE I cohort, a prospective cohort initiated in 1974 in Washington County, Maryland, we conducted a neste …
The objective of our study was to investigate the association of antibodies to oral bacteria and the risk of colon cancer …
Recent advances in oral anticancer agents for colon cancer.
Shukla RK. Shukla RK. Future Oncol. 2013 Dec;9(12):1893-908. doi: 10.2217/fon.13.137. Future Oncol. 2013. PMID: 24295419 Review.
To provide therapeutic alternatives to intravenous colon chemotherapy major recent research is focusing on the development of oral chemotherapeutic agents with the intention to improve the quality of life of patients. Initially 5-fluorouracil was most commonly used …
To provide therapeutic alternatives to intravenous colon chemotherapy major recent research is focusing on the development of oral …
Can Oral Tolerance Explain the Inconsistencies Associated with Total Dietary Diversity and Colon Cancer? A Mechanistic Systematic Review.
Jabbari M, Barati M, Fathollahi A, Javanmardi F, Hemmati F, Farahmand F, Mirmiran P, Eini-Zinab H, Mousavi Khaneghah A. Jabbari M, et al. Nutr Cancer. 2021;73(11-12):2101-2112. doi: 10.1080/01635581.2020.1819349. Epub 2020 Sep 17. Nutr Cancer. 2021. PMID: 32940541 Review.
Among the gastrointestinal tract cancers, the risk of colon cancer is strongly dependent on dietary factors. For the first time in the current review, all the original case-control studies, associated with the correlation between total dietary diversity score and …
Among the gastrointestinal tract cancers, the risk of colon cancer is strongly dependent on dietary factors. For the first tim …
Identification of Molecular Subtypes and a Prognostic Signature Based on Inflammation-Related Genes in Colon Adenocarcinoma.
Qiu C, Shi W, Wu H, Zou S, Li J, Wang D, Liu G, Song Z, Xu X, Hu J, Geng H. Qiu C, et al. Front Immunol. 2021 Dec 23;12:769685. doi: 10.3389/fimmu.2021.769685. eCollection 2021. Front Immunol. 2021. PMID: 35003085 Free PMC article.
Both tumour-infiltrating immune cells and inflammation-related genes that can mediate immune infiltration contribute to the initiation and prognosis of patients with colon cancer. In this study, we developed a method to predict the survival outcomes among colon …
Both tumour-infiltrating immune cells and inflammation-related genes that can mediate immune infiltration contribute to the initiation and p …
Microbial metabolite restricts 5-fluorouracil-resistant colonic tumor progression by sensitizing drug transporters via regulation of FOXO3-FOXM1 axis.
Ghosh S, Singh R, Vanwinkle ZM, Guo H, Vemula PK, Goel A, Haribabu B, Jala VR. Ghosh S, et al. Theranostics. 2022 Jul 18;12(12):5574-5595. doi: 10.7150/thno.70754. eCollection 2022. Theranostics. 2022. PMID: 35910798 Free PMC article.
Although there is mounting evidence that commensal gut microbiota is essential for effective colon cancer treatment, the detailed molecular mechanisms and the role of gut microbial metabolites remain elusive. The goal of this study is to decipher the impact and mech …
Although there is mounting evidence that commensal gut microbiota is essential for effective colon cancer treatment, the detai …
Colon Cancer-Associated Fusobacterium nucleatum May Originate From the Oral Cavity and Reach Colon Tumors via the Circulatory System.
Abed J, Maalouf N, Manson AL, Earl AM, Parhi L, Emgård JEM, Klutstein M, Tayeb S, Almogy G, Atlan KA, Chaushu S, Israeli E, Mandelboim O, Garrett WS, Bachrach G. Abed J, et al. Front Cell Infect Microbiol. 2020 Aug 7;10:400. doi: 10.3389/fcimb.2020.00400. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 32850497 Free PMC article.
In animal models, fusobacteria accelerate CRC progression. Targeting F. nucleatum may reduce fusobacteria cancer progression and therefore determining the origin of CRC F. nucleatum and the route by which it reaches colon tumors is of biologic and therapeutic import …
In animal models, fusobacteria accelerate CRC progression. Targeting F. nucleatum may reduce fusobacteria cancer progression and ther …
Chitosan nanoparticles for oral photothermally enhanced photodynamic therapy of colon cancer.
Chen G, Zhao Y, Xu Y, Zhu C, Liu T, Wang K. Chen G, et al. Int J Pharm. 2020 Nov 15;589:119763. doi: 10.1016/j.ijpharm.2020.119763. Epub 2020 Sep 6. Int J Pharm. 2020. PMID: 32898629
Additionally, significant therapeutic efficacy for cancer treatment were observed in vivo after oral administration of 5-ALA&IR780@CS NPs, without causing any overt adverse effects. Our work highlights the great potential of photothermally enhanced photodynamic …
Additionally, significant therapeutic efficacy for cancer treatment were observed in vivo after oral administration of 5-ALA&a …
Effects of oral bovine lactoferrin on a mouse model of inflammation associated colon cancer.
Tanaka H, Gunasekaran S, Saleh DM, Alexander WT, Alexander DB, Ohara H, Tsuda H. Tanaka H, et al. Biochem Cell Biol. 2021 Feb;99(1):159-165. doi: 10.1139/bcb-2020-0087. Epub 2020 Sep 9. Biochem Cell Biol. 2021. PMID: 32905707 Free article.
Patients with ulcerative colitis or colonic Crohn's disease have a significantly increased risk of developing colorectal cancer. Bovine lactoferrin (bLF) reportedly inhibited the development of colon cancer in rats and mice, and in a placebo controlled …
Patients with ulcerative colitis or colonic Crohn's disease have a significantly increased risk of developing colorectal cancer …
5,277 results

Searches related to "colon cancer oral"